StockData
CalciMedica, Inc. logo

CalciMedica, Inc. (CALC) stock

CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$1.17−0.05 (-4.10%)

Close on Nov 18, 2026Market cap $39.95MP/E –Yield –

CalciMedica free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

CalciMedica's free cash flow for the twelve months ending Jun 30, 2026 was -$19.12M. For fiscal 2025 it was -$21.21M. The highest annual figure on record is -$11.76M in fiscal 2022.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$21.21M–
FY2024Dec 31, 2024-$21.15M–
FY2023Dec 31, 2023-$25.81M–
FY2022Dec 31, 2022-$11.76M–
FY2021Dec 31, 2021-$31.99M–
FY2020Dec 31, 2020-$33.09M–
FY2019Dec 31, 2019-$31.82M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.62M–
Q1 FY2026Mar 31, 2026-$4.86M–
Q4 FY2025Dec 31, 2025-$4.86M–
Q3 FY2025Sep 30, 2025-$4.79M–
Q2 FY2025Jun 30, 2025-$6.68M–
Q1 FY2025Mar 31, 2025-$4.89M–
Q4 FY2024Dec 31, 2024-$4.97M–
Q3 FY2024Sep 30, 2024-$4.67M–
Q2 FY2024Jun 30, 2024-$6.79M–
Q1 FY2024Mar 31, 2024-$4.72M–
Q4 FY2023Dec 31, 2023-$3.61M–
Q3 FY2023Sep 30, 2023-$4.57M–
Q2 FY2022Jun 30, 2022-$2.22M–
Q1 FY2022Mar 31, 2022-$3.63M–
Q4 FY2021Dec 31, 2021-$8.96M–
Q3 FY2021Sep 30, 2021-$5.68M–
Q2 FY2021Jun 30, 2021-$7.95M–
Q1 FY2021Mar 31, 2021-$9.40M–
Q4 FY2020Dec 31, 2020-$10.60M–
Q3 FY2020Sep 30, 2020-$5.40M–
Q2 FY2020Jun 30, 2020-$6.23M–
Q1 FY2020Mar 31, 2020-$10.86M–
Q4 FY2019Dec 31, 2019-$10.02M–

More CalciMedica figures

See a number that looks wrong?